Advertisement
Last week I questioned whether Australia had backed the wrong vaccine, given research suggested that AstraZeneca was more effective against the Delta strain than Pfizer.
A new study analysing COVID-19 related outcomes from Bahrain between December 2020 and July 2021 shows that recipients of the AstraZeneca vaccine were hospitalised less and experienced less death than recipients of three other vaccines – Pfizer, Sinopharm and Sputnik.
Below is a summary of this study:
The full text of this article is available to MacroBusiness subscribers
Cancel at any time through our billing provider, Stripe
About the author
Leith van Onselen is Chief Economist at the MB Fund and MB Super. He is also a co-founder of MacroBusiness.
Leith has previously worked at the Australian Treasury, Victorian Treasury and Goldman Sachs.